Summary
Updated Aug 30, 2026
Michael F. Demane files SEC Form 4 reports at NEVRO CORP (NVRO). 2 SEC Form 4 filings on record going back to 2024, most recently on 3 April 2025.
Recent Transactions
5Every recent SEC Form 4 transaction Michael F. Demane has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Michael F. Demane's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Neil Kumar - $53.07M of BBIO open-market activity in the last 12 months
- Randal J. Kirk - $52.87M of PGEN open-market activity in the last 12 months
- ORBIMED ADVISORS LLC - $51.68M of ELVN open-market activity in the last 12 months
- Casdin Partners Master Fund, L.P. - $49.54M of BLFS open-market activity in the last 12 months
- Gary S. Guthart - $48.79M of ISRG open-market activity in the last 12 months
- Robert B. Ford - $48.22M of ABT open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Michael F. Demane?
Michael F. Demane is a corporate insider of NEVRO CORP (NVRO). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Michael F. Demane last file a Form 4?
The most recent primary Form 4 on record is dated 3 April 2025, one of 2 filings going back to 2024.
Where can I see all of Michael F. Demane's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Michael F. Demane and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
